Eptifibatide acetate

SKU: orb1818856

Description

Eptifibatide, also co-promoted by Schering-Plough/Essex, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 1248559-53-6
• MW: 892.01
• Purity: >98%
• Formula: C₃₇H₅₃N₁₁O₁₁S₂
• SMILES: NC(NCCCC[C@@H]1NC(CCSSC[C@@H](C(N)=O)NC([C@@H]2CCCN2C([C@@H](NC([C@@H](NC(CNC1=O)=O)CC(O)=O)=O)Cc(c[nH]3)c4c3cccc4)=O)=O)=O)=N

Storage & Handling

• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

448812